IM Cannabis
Biotechnology, Cannabis, Community And Lifestyle · 435 employees
IM Cannabis (NASDAQ: IMCC, CSE: IMCC) is a leading international cannabis company providing premium products to medical patients and adult-use recreational consumers. IM Cannabis is one of the very few companies with operations in Israel, Germany, and Canada, the three largest federally legal markets. The ecosystem created through its international operations leverages the Company's unique data-dr
Funding history
- Funding Round — $2.2M — Jan 2026
- Funding Round — $4.1M — Jul 2025
- Series pre-seed — $27K — Nov 2024
- Funding Round — $302K — Jul 2020
- Funding Round — $12K — Jul 2020
Recent signals
- Mar 31, 2026: Acquired IM Cannabis to acquire 51% of Black Axe Technologies
- Mar 17, 2026: Acquired IMC to acquire 51% of Blackaxe Technologies
- Jan 26, 2026: Raised $2.2M
- Dec 12, 2025: IM Cannabis Corp. Appoints Asi Levi as Chief Financial Officer
- Jul 31, 2025: Raised $4.1M
- Nov 20, 2024: Raised $27K in Series pre-seed
- Mar 30, 2022: Acquired Im Cannabis Closes Previously Announced Acquisition Of Oranim Pharm, Jerusalem'S Leading Medical Cannabis Pharmacy
- Jul 09, 2020: Raised $302K
See plans & pricing → Track IM Cannabis’s funding, hiring, and signals — with verified contacts — on Fundz.